<DOC>
	<DOCNO>NCT01565447</DOCNO>
	<brief_summary>This purpose study characterize walk pattern child diagnose Acute Lymphoblastic Leukemia ( ALL ) Lymphoblastic Lymphoma ( LL ) different time treatment protocol completion treatment . Their walking pattern compare child without ALL LL see walk pattern different specific time treatment program 10 year completion treatment . The investigator gather data observe child walk , run , hop one foot climb stair record walk pattern pressure sensitive mat . The investigator compare data child without ALL LL .</brief_summary>
	<brief_title>Acute Lymphoblastic Leukemia ( ALL ) Lymphoblastic Lymphoma Gait Parameters Study</brief_title>
	<detailed_description>Cases identify referred primary oncologist Childhood Cancer Survivorship team . When possible subject identify contacted via telephone routine clinic visit determine interest study . Two hundred subject recruit participation goal 5-10 subject 14 time point across treatment protocol survivorship . These time point include : diagnosis , start consolidation therapy , start interim maintenance therapy , start delay intensification therapy , Day 29 delay intensification therapy , start interim maintenance II therapy ( applicable ) , Day 1 cycle 1,3,5 maintenance therapy , end therapy , 1 , 3 , 5 , 10 year therapy ( +/-1 year ) . Clinical data collect medical record , roadmaps document cancer-directed therapy , direct patient interview examination physical therapist study evaluation . Clinical data include : Date birth ( calculate age diagnosis current age ) ; Gender ; Race Ethnicity ; Primary cancer diagnosis ; Date Primary Cancer Diagnosis ; Chemotherapeutic agent receive ( agent name , cumulative dose date receive ) ; Radiation therapy ( date receive , site radiate , dose deliver ) ; Any clinical condition affect musculoskeletal performance ; Dates previous PT ; Pain score time study participation . Height , weight , shoe size leg length collect time study participation . Subjects complete self report PedsQLâ„¢ Generic Core Scale parent complete parental report . Observation gait assessment include hop one foot , run walk 30 ' ascending/descending stair . Temporal spatial gait parameter record GaitRite mat</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>1 . Age 227 year age 2 . Diagnosis acute lymphoblastic leukemia lymphoblastic lymphoma 3 . Currently undergo treatment ALL LL complete treatment ALL LL last 10 year . Exclusion Criteria 1 . Relapsed ALL LL 2 . Received stem cell transplant , either autologous allogeneic 3 . Non ambulatory status prior diagnosis acute lymphoblastic leukemia lymphoblastic lymphoma</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>27 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>